Alzheimer’s Disease

The potential druggability of OAS1 leading to new AD and COVID-19 treatments

Identifying innate immune system genes linked to AD

Microglia associated with longevity and a lower AD risk

Identifying a new link between TREM2 and IL-4 signaling in microglia

The OAS1 gene increases risk of AD and COVID-19

Investigating microstructural properties of SWM in Alzheimer’s disease

Superficial white matter: exciting research in the field

Hopes and challenges in AD research

Understanding tau proteostasis using iPSC

Model of pathology for age of onset heterogeneity in familial Alzheimer’s disease

Viral infections and dementia

The Cognition and Flow Study: the effects of brain training on brain blood flow

The benefits of GWAS in understanding Alzheimer’s disease

Therapeutic development in Alzheimer’s disease and the lack of funding

Cross neurodegenerative disease genetic analysis: similarities and differences

Identifying new therapeutic targets for neurodegenerative diseases